Spero Therapeutics, Inc. Increase (Decrease) in Other Operating Assets
Spero Therapeutics, Inc. (SPRO) reported Increase (Decrease) in Other Operating Assets of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-03-26
- Spero Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was $0.00.
- Spero Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was $0.00.
- Spero Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2025-06-30 was $0.00.
- Spero Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2025-03-31 was $0.00.
- Spero Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2025 was $0.00.
- Spero Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2024 was -$282.00K, a 28300.00% decline from fiscal 2023.
- Spero Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2023 was $1.00K, a 66.67% decline from fiscal 2022.
- Spero Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2022 was $3.00K, a 99.06% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 3 month as first filed | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | $0.00 derived: sum of 3 quarters · filed 2026-03-26 | $0.00 10-K · filed 2026-03-26 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 4 quarters · filed 2026-03-26 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $0.00 10-Q · filed 2025-08-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-26 | -$281.00K derived: sum of 4 quarters · filed 2026-03-26 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | -$281.00K derived: sum of 3 quarters · filed 2026-03-26 | -$281.00K derived: sum of 4 quarters · filed 2026-03-26 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$281.00K derived: sum of 2 quarters · filed 2026-03-26 | -$281.00K derived: sum of 3 quarters · filed 2026-03-26 | -$282.00K 10-K · filed 2026-03-26 | |
| 2024-09-30 | -$281.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$281.00K derived: sum of 2 quarters · filed 2025-11-13 | -$282.00K 10-Q · filed 2025-11-13 | -$281.00K derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$1.00K 10-Q · filed 2025-08-12 | $0.00 derived: sum of 3 quarters · filed 2025-08-12 | $0.00 derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | -$1.00K 10-Q · filed 2025-05-13 | $0.00 derived: sum of 2 quarters · filed 2025-05-13 | $0.00 derived: sum of 3 quarters · filed 2025-05-13 | $0.00 derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $1.00K derived: sum of 2 quarters · filed 2025-03-27 | $1.00K derived: sum of 3 quarters · filed 2025-03-27 | $1.00K 10-K · filed 2025-03-27 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | $1.00K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $0.00 10-Q · filed 2024-08-05 | $1.00K derived: sum of 3 quarters · filed 2024-08-05 | $908.00K derived: sum of 4 quarters · filed 2024-08-05 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-15 | $1.00K derived: sum of 2 quarters · filed 2024-05-15 | $908.00K derived: sum of 3 quarters · filed 2024-05-15 | $288.00K derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $908.00K derived: sum of 2 quarters · filed 2024-03-13 | $288.00K derived: sum of 3 quarters · filed 2024-03-13 | $3.00K 10-K · filed 2024-03-13 | |
| 2022-09-30 | $907.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $287.00K derived: sum of 2 quarters · filed 2023-11-13 | $2.00K 10-Q · filed 2023-11-13 | $328.00K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | -$620.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$905.00K 10-Q · filed 2023-08-10 | -$579.00K derived: sum of 3 quarters · filed 2023-08-10 | -$594.00K derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | -$285.00K 10-Q · filed 2023-05-11 | $285.00K 10-Q · filed 2022-05-16 | $41.00K derived: sum of 2 quarters · filed 2023-05-11 | $26.00K derived: sum of 3 quarters · filed 2023-05-11 | |
| 2021-12-31 | $326.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $311.00K derived: sum of 2 quarters · filed 2023-03-30 | $319.00K 10-K · filed 2023-03-30 | ||
| 2021-09-30 | -$15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$7.00K 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | $8.00K 10-Q · filed 2022-08-10 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $129.00K derived: sum of 2 quarters · filed 2022-03-31 | $666.00K derived: sum of 3 quarters · filed 2022-03-31 | $1.89M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $129.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $666.00K derived: sum of 2 quarters · filed 2021-11-10 | $1.89M 10-Q · filed 2021-11-10 | $4.37M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $537.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.76M 10-Q · filed 2021-08-05 | $4.24M derived: sum of 3 quarters · filed 2021-08-05 | $3.93M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-03-31 | $1.22M 10-Q · filed 2021-05-06 | $3.70M derived: sum of 2 quarters · filed 2021-05-06 | $3.39M derived: sum of 3 quarters · filed 2021-05-06 | $4.57M derived: sum of 4 quarters · filed 2021-05-06 | |
| 2019-12-31 | $2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $2.17M derived: sum of 2 quarters · filed 2021-03-11 | $3.35M derived: sum of 3 quarters · filed 2021-03-11 | $2.91M 10-K · filed 2021-03-11 | |
| 2019-09-30 | -$313.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $865.00K derived: sum of 2 quarters · filed 2020-11-05 | $432.00K 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $745.00K 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | -$433.00K 10-Q · filed 2020-05-08 | ||||
| 2018-12-31 | $1.19M 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |